GH1 and in situ carcinoma: We have identified the cell types expressing SOCS and CIS mRNA, and quantified the relative levels of expression in human breast tumours of increasing severity from a preinvasive stage (ductal carcinoma) to invasive carcinoma, for which we have previously documented the gene expression levels for both GH and PRL receptors (Mertani et al, 1998).